Chronic diseases require a lifetime of long-term follow-up. Randomised controlled trials are considered the most robust ...
Researchers have developed two advanced AI models, InstaNovo and InstaNovo+, that significantly improve accuracy in de novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback